Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | PHGDH | O43175 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4552761 | 0.97 | LMNA (0.45) | LMNAL3MBTL1MEN1HTTKMT2A | |
| Hydrochloric Acid SCHEMBL9080600 | 0.95 | LMNA (0.43) | LMNAL3MBTL1MEN1HTTKMT2A | |
| SCHEMBL21075816 | 0.80 | LTA4H (0.48) | LMNAL3MBTL1MEN1HTTKMT2A | |
| Sebacic Acid SCHEMBL28496083 | 0.79 | HDAC6 (0.49) | LMNAHTTSMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL6835309 | 0.78 | ALDH1A1 (0.61) | MEN1KMT2ASMN1; SMN2TSHRCA1 | |
| SCHEMBL11651548 | 0.76 | HTT (0.47) | LMNAL3MBTL1MEN1HTTKMT2A | |
| SCHEMBL6567263 | 0.76 | ALDH1A1 (0.55) | LMNAMEN1HTTKMT2ASMN1; SMN2 | |
| SCHEMBL4642650 | 0.76 | HTT (0.42) | LMNAL3MBTL1MEN1HTTKMT2A | |
| SCHEMBL28125968 | 0.76 | MEN1 (0.42) | LMNAL3MBTL1MEN1HTTKMT2A | |
| SCHEMBL609177 | 0.74 | L3MBTL1 (0.43) | LMNAL3MBTL1MEN1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118185689-A | Lubricating oil additive and application thereof | 锦州康泰润滑油添加剂有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-111334129-A | Preparation method of low-temperature sintered nano-silver conductive ink | 善仁（浙江）新材料科技有限公司 | 2020-06-26 | — | — | CN | claimed |
| CN-119869473-A | MOFs derived carbon-loaded sodium alginate adsorbent, preparation method and application | 中国人民解放军火箭军工程大学 | 2025-04-25 | — | — | CN | disclosed |
| CN-222057380-U | Synthesis equipment of unsymmetrical dimethylhydrazine | 石家庄市冀晟化工有限责任公司 | 2024-11-26 | — | — | CN | disclosed |
| US-11912647-B2 | Diversity-oriented synthesis of N,N,O-trisubstituted hydroxylamines from alcohols and amines by N—O bond formation | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2024-02-27 | — | — | US | disclosed |
| US-20210363098-A1 | DIVERSITY-ORIENTED SYNTHESIS OF N,N,O-TRISUBSTITUTED HYDROXYLAMINES FROM ALCOHOLS AND AMINES BY N-O BOND FORMATION | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2021-11-25 | — | — | US | disclosed |
| EP-3802733-A1 | LIQUID CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2021-04-14 | — | — | EP | disclosed |
| US-20210020852-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2021-01-21 | — | — | US | disclosed |
| CN-111334129-A | Preparation method of low-temperature sintered nano-silver conductive ink | 善仁（浙江）新材料科技有限公司 | 2020-06-26 | — | — | CN | disclosed |
| US-20200087270-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS AG (CH) | 2020-03-19 | — | — | US | disclosed |
| WO-2019238567-A1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2019-12-19 | — | — | WO | disclosed |
| EP-1058678-A2 | METAL-CATALYZED ARYLATIONS AND VINYLATIONS OF HYDRAZINES, HYDRAZONES, HYDROXYLAMINES AND OXIMES | Massachusetts Institute of Technology (US) | 2000-12-13 | — | — | EP | disclosed |
| WO-1999043643-A2 | METAL-CATALYZED ARYLATIONS AND VINYLATIONS OF HYDRAZINES, HYDRAZONES, HYDROXYLAMINES AND OXIMES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1999-09-02 | — | — | WO | disclosed |
| EP-0552852-B1 | Polycondensed polysilazane and method of producing same | TOA NENRYO KOGYO KK (JP) | 1997-01-02 | — | — | EP | disclosed |
| US-5574037-A | MODULATED BY SINO-ATRIAL NODE, ANTIISCHEMIC AGENT | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1996-11-12 | — | — | US | disclosed |
| US-5328620-A | Overbased compound, metal salt of dithiophosphoric acid, ashless dispersant | THE LUBRIZOL CORPORATION (US) | 1994-07-12 | — | — | US | disclosed |
| EP-0552852-A2 | Polycondensed polysilazane and method of producing same | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1993-07-28 | — | — | EP | disclosed |
| US-4975512-A | Crosslinking with amine, ammonium, hydrazine | PETROLEUM ENERGY CENTER (JP) | 1990-12-04 | — | — | US | disclosed |
| EP-0304239-A1 | Reformed polysilazane and method of producing same | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1989-02-22 | — | — | EP | disclosed |
| US-4006127-A | Cationic diazacyanine dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1977-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200087270-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NLRP1, NLRP3, NOD1 | LMNA 1699/4885L3MBTL1 4789/4885MEN1 3390/4885 |
| US-20210363098-A1 | DIVERSITY-ORIENTED SYNTHESIS OF N,N,O-TRISUBSTITUTED HYDROXYLAMINES FROM ALCOHOLS AND AMINES BY N-O BOND FORMATION | ADH5, ADH1A, NAT1 | LMNA 3209/4885L3MBTL1 2634/4885MEN1 3283/4885 |
| US-11912647-B2 | Diversity-oriented synthesis of N,N,O-trisubstituted hydroxylamines from alcohols and amines by N—O bond formation | ADH5, ADH1A, NAT1 | LMNA 3243/4885L3MBTL1 2657/4885MEN1 3153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.